bpc-157 pharmacokinetics half-life study as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Therapeutic peptides and proteins: Status

A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent, wherein the therapeutic agent is an antioxidant or anti-apoptotic agent, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration

The citrullination of epithelial neutrophil-activating peptide 78/CXCL5 chemokine by human peptidylarginine deiminase (PAD) present in the gut, has been reported to stimulate the production of monocyte recruiting chemokines and promote inflammation (Yoshida et al

The storage parameters are straightforward and non-negotiable

This finding has significant implications for wound healing research in radiation-compromised tissue models

Steqeyma hit U.S

Users report enhanced skin quality and faster scar resolution as additional benefits